These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1349794

  • 1. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
    Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP.
    Anticancer Res; 1992; 12(2):419-25. PubMed ID: 1349794
    [Abstract] [Full Text] [Related]

  • 2. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
    Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.
    Cancer Res; 1990 Jul 15; 50(14):4332-7. PubMed ID: 1973070
    [Abstract] [Full Text] [Related]

  • 3. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA.
    Cancer Res; 1991 Jan 15; 51(2):556-67. PubMed ID: 1670762
    [Abstract] [Full Text] [Related]

  • 4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 5. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb 15; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R.
    N Engl J Med; 1988 Nov 10; 319(19):1239-45. PubMed ID: 2903446
    [Abstract] [Full Text] [Related]

  • 9. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul 10; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Follow-up study of HER-2/neu amplification in primary breast cancer.
    Clark GM, McGuire WL.
    Cancer Res; 1991 Feb 01; 51(3):944-8. PubMed ID: 1988136
    [Abstract] [Full Text] [Related]

  • 12. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R, Apple SK, He J, Gornbein JA, Chang HR.
    Breast J; 2005 Feb 01; 11(6):433-9. PubMed ID: 16297088
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.
    Homaei-Shandiz F, Ghavam-Nassiri MR, Sharifi N, Homaei-Shandiz AH, Taghizadeh-Kermani A, Torshizi SA, Ghafarzadegan K.
    Saudi Med J; 2006 Dec 01; 27(12):1810-4. PubMed ID: 17143354
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Dec 01; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 15. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
    Imyanitov EN, Chernitsa OI, Serova OM, Nikoforova IF, Pluzhnikova GF, Knyazev PG.
    Neoplasma; 1993 Dec 01; 40(1):35-9. PubMed ID: 7688867
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN.
    Hum Pathol; 2001 Dec 01; 32(12):1344-50. PubMed ID: 11774167
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL, Borelli KA, Hsu PH.
    Mod Pathol; 1997 Jul 01; 10(7):720-7. PubMed ID: 9237184
    [Abstract] [Full Text] [Related]

  • 18. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R, Lee CS, Hui R, McCaul K, Horsfall DJ, Sutherland RL.
    Clin Cancer Res; 1996 Jul 01; 2(7):1177-84. PubMed ID: 9816285
    [Abstract] [Full Text] [Related]

  • 19. Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis.
    Poltinnikov IM, Rudoler SB, Tymofyeyev Y, Kennedy J, Anne PR, Curran WJ.
    Am J Clin Oncol; 2006 Feb 01; 29(1):71-9. PubMed ID: 16462507
    [Abstract] [Full Text] [Related]

  • 20. Human breast cancer: correlation study between HER-2/neu amplification and prognostic factors in an unselected population.
    Descotes F, Pavy JJ, Adessi GL.
    Anticancer Res; 1993 Feb 01; 13(1):119-24. PubMed ID: 8097388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.